가열살균한 Lactobacillus rhamnosus와 Lactobacillus plantarum의 콜레스테롤 저하 효과
Hypocholesterolemic Effect of Lyophilized, Heat-Killed Lactobacillus rhamnosus and Lactobacillus plantarum
0
조회
0
다운로드
19
인용
0
참고문헌
키워드
초록
Lactic acid bacteria (LAB) were well known to enhance the intestinal health of human. For the development of pharmaceutical LAB, it was screened that the LAB with activity lowering the cholesterol in vitro and evaluated the hypocholestrolemic effect of live and heat-killed (HK) LAB on rats. The selected Lactobacillus plantarum CBT 1209 and Lactobacillus rhamnosus CBT 1702 had the deconjugation of bile salts and assimilation of cholesterol micelles activities from laboratory media. The mixture of 1702 and 1209 strains was administrated to the rats with high cholesterol diet. The experiment performed by 4 groups which were control, HCD, LLAB, HKLAB groups. The hypocholesterolemic effect of LAB (strains 1702, 1209) at blood level, the phenomena of AI decreasing through LDL-cholesterol dwindling, was assessed. This effect of 1702 and 1209 was enhanced when it comes to be the HKLAB more the live-LAB. This data means that the Lactobacillus rhamnosus CBT 1702 and Lactobacillus plantarum CBT 1209 were very useful functional ingredient for hypercholesterolemia.
Abstract
Lactic acid bacteria (LAB) were well known to enhance the intestinal health of human. For the development of pharmaceutical LAB, it was screened that the LAB with activity lowering the cholesterol in vitro and evaluated the hypocholestrolemic effect of live and heat-killed (HK) LAB on rats. The selected Lactobacillus plantarum CBT 1209 and Lactobacillus rhamnosus CBT 1702 had the deconjugation of bile salts and assimilation of cholesterol micelles activities from laboratory media. The mixture of 1702 and 1209 strains was administrated to the rats with high cholesterol diet. The experiment performed by 4 groups which were control, HCD, LLAB, HKLAB groups. The hypocholesterolemic effect of LAB (strains 1702, 1209) at blood level, the phenomena of AI decreasing through LDL-cholesterol dwindling, was assessed. This effect of 1702 and 1209 was enhanced when it comes to be the HKLAB more the live-LAB. This data means that the Lactobacillus rhamnosus CBT 1702 and Lactobacillus plantarum CBT 1209 were very useful functional ingredient for hypercholesterolemia.
참고문헌 (22)
- Anderson, J. W, "Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans", J. Am. Coll. Nutr, 18(1), pp.43~50 (1999)
- Brown, M. S, "Method and composition for identifying substances which activate transcription of the LDL receptor gene", Biotechnology Advances, 13(4), pp.724~725 (1995)
- Creager, M. A, "Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans", J. Clin. Invest., 86(1), pp.228~234 (1990)
- Dora, "Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated form the human gut. Appl", Environ Microbiology, 68(9), pp.4689~4693 (2002)
- Grundy, S. M, "Quantitative isolation and gas-liquid chromatographic analysis of total and fecal bile acids", J Lipid Res, 6, pp.397~410 (1965)
- Holme, I, "Cholesterol reduction and its impact on coronary artery disease and total mortality", Am. J. Cardiol, 76(9), pp.10~17 (1995)
- Jung, H. K, "Cholesterol-lowering effect of lactic acid bacteria and fermented milks as probiotic functional foods", Food Industry and Nutrition, 5(2), pp.29~35 (2000)
- Kesaniemi, Y. A, "Low vs high dietary fiber and serum, biliary and fecal lipids in middle-aged men", Am. J. Clin. Nutr, 51(6), pp.1007~1012 (1990)
- Kimoto, H, "Cholesterol removal from media by Lactococci", J. Dairy Sci, 85, pp.3182~3188 (2002)
- Liatis, S, "The consumption of bread enriched with beta-glucan reduces LDL-cholesterol and improves insulin resistance in patients with type2 diabetes", Diabetes Metab, 19 (2009)
- Lin, M. Y, "Reduction of cholesterol by lactobacillus acidophilus in culture broth", J. Food Drug Anal, 8, pp.113~118 (2000)
- Liong, M. T, "Acid and bile tolerance and cholesterol removal ability of Lactobacilli strains", J. Dairy Sci, 88, pp.55~66 (2005)
- Mazza, G, "Functional Foods: Biochemical and Processing aspects", pp.234~ (1998), Technomic publishing company. Inc
- Mckenney, J. M., "Lipid management: tools for getting to the goal", Am. J. Manag. Care, 70(9), pp.S299~S306 (2001)
- Miettinen, T. A, "Cholesterol absorption inhibition: a strategy for cholesterol-lowering therapy", Int. J. Clin. Pract, 55(10), pp.710~716 (2001)
- Miettinen, T. A, "Serum lipids and cholesterol metabolism during guar gum, plantago ovata and high fiber treatments", Clin Chim Acta., 183(3), pp.253~262 (1989)
- Myant, N. B, "Cholesterol 7aaahydroxylase", J. LipidRes, 18(2), pp.135~153 (1977)
- Yousuke Seyama, "Cholestanol Metabolism, Molecular Pathology, and Nutritional Implications", Journal of Medicinal Food, 6(3), pp.217~224 (2003), 한국식품영양과학회
- Third Report of the national cholesterol education program (NCEP) expert panel “High Blood Cholesterol”, "Stephen, H", 3670~, pp.NIH Publication No. 01 (2001)
- St-Onge, M. P, "Consumption of fermented and non fermented dairy products: effects on cholesterol concentration and metabolism", Am. J. Clin. Nutr, 71(3), pp.674~681 (2000)
- Vaclav Vetvicka, "Immunological Effects of Yeast- and Mushroom-Derived β-Glucans", Journal of Medicinal Food, 11(4), pp.615~622 (2008), 한국식품영양과학회
- Vetvicka V, "Physiological effects of different types of beta-glucan", Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 151(2), pp.225~231 (2007)